Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((antidepressive AND agents) OR (depressive AND disorder, AND major)):

Search results

Items: 1 to 20 of 116211

1.

A randomized, double-blind study comparing the efficacy and safety of trazodone once-a-day and venlafaxine extended-release for the treatment of patients with major depressive disorder.

Fagiolini A, Albert U, Ferrando L, Herman E, Muntean C, Pálová E, Cattaneo A, Comandini A, Giorgio DD, Di Loreto G, Olivieri L, Salvatori E, Tongiani S, Kasper S.

Int Clin Psychopharmacol. 2020 Jan 15. doi: 10.1097/YIC.0000000000000304. [Epub ahead of print]

PMID:
31972628
2.

Association between COMT gene Val108/158Met and antidepressive treatment response: a meta-analysis.

Tang Z, Zhang S, Guo D, Wang H.

Gene. 2020 Jan 20:144333. doi: 10.1016/j.gene.2020.144333. [Epub ahead of print] Review.

PMID:
31972309
3.

Antidepressants normalize brain flexibility associated with multi-dimensional symptoms in major depressive patients.

Tian S, Zhang S, Mo Z, Chattun MR, Wang Q, Wang L, Zhu R, Shao J, Wang X, Yao Z, Si T, Lu Q.

Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 20:109866. doi: 10.1016/j.pnpbp.2020.109866. [Epub ahead of print]

PMID:
31972187
4.

Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders.

Mok SW, Wong VK, Lo HH, de Seabra Rodrigues Dias IR, Leung EL, Law BY, Liu L.

Pharmacol Ther. 2020 Jan 20:107480. doi: 10.1016/j.pharmthera.2020.107480. [Epub ahead of print] Review.

PMID:
31972182
5.

Anti-Suicidal Efficacy of Repetitive Transcranial Magnetic Stimulation in Depressive Patients: A Retrospective Analysis of a Large Sample.

Abdelnaim MA, Langguth B, Deppe M, Mohonko A, Kreuzer PM, Poeppl TB, Hebel T, Schecklmann M.

Front Psychiatry. 2020 Jan 8;10:929. doi: 10.3389/fpsyt.2019.00929. eCollection 2019.

6.

Structural and Functional Abnormities of Amygdala and Prefrontal Cortex in Major Depressive Disorder With Suicide Attempts.

Wang L, Zhao Y, Edmiston EK, Womer FY, Zhang R, Zhao P, Jiang X, Wu F, Kong L, Zhou Y, Tang Y, Wei S.

Front Psychiatry. 2020 Jan 8;10:923. doi: 10.3389/fpsyt.2019.00923. eCollection 2019.

7.

Dysfunction of Pre-Attentive Visual Information Processing in Drug-Naïve Women, But Not Men, During the Initial Episode of Major Depressive Disorder.

Yang X, Wang Q, Qiao Z, Qiu X, Han D, Zhu X, Zhang C, Yang Y.

Front Psychiatry. 2020 Jan 8;10:899. doi: 10.3389/fpsyt.2019.00899. eCollection 2019.

8.

Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank.

Coleman JRI, Peyrot WJ, Purves KL, Davis KAS, Rayner C, Choi SW, Hübel C, Gaspar HA, Kan C, Van der Auwera S, Adams MJ, Lyall DM, Choi KW; on the behalf of Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Dunn EC, Vassos E, Danese A, Maughan B, Grabe HJ, Lewis CM, O'Reilly PF, McIntosh AM, Smith DJ, Wray NR, Hotopf M, Eley TC, Breen G.

Mol Psychiatry. 2020 Jan 23. doi: 10.1038/s41380-019-0546-6. [Epub ahead of print]

PMID:
31969693
9.

Hopelessness and its correlates with clinical outcomes in an outpatient setting.

Serafini G, Lamis DA, Aguglia A, Amerio A, Nebbia J, Geoffroy PA, Pompili M, Amore M.

J Affect Disord. 2019 Nov 30;263:472-479. doi: 10.1016/j.jad.2019.11.144. [Epub ahead of print]

PMID:
31969280
10.

A 12-week multidomain intervention for late-life depression: a community-based randomized controlled trial.

Roh HW, Hong CH, Lim HK, Chang KJ, Kim H, Kim NR, Choi JW, Lee KS, Cho SM, Park B, Son SJ.

J Affect Disord. 2019 Dec 9;263:437-444. doi: 10.1016/j.jad.2019.12.013. [Epub ahead of print]

PMID:
31969275
11.

Alexithymia as a possible specifier of adverse outcomes: Clinical correlates in euthymic unipolar individuals.

Serafini G, De Berardis D, Valchera A, Canepa G, Geoffroy PA, Pompili M, Amore M.

J Affect Disord. 2019 Oct 31;263:428-436. doi: 10.1016/j.jad.2019.10.046. [Epub ahead of print]

PMID:
31969274
12.

Association between major depressive disorder and subsequent tinnitus: A population-based study.

Kao LT, Shih JH, Yeh CB, Wang CH, Chen HC, Chien WC, Li IH.

J Affect Disord. 2019 Nov 30;263:367-372. doi: 10.1016/j.jad.2019.11.141. [Epub ahead of print]

PMID:
31969266
13.

Reverse translation of major depressive disorder symptoms: A framework for the behavioural phenotyping of putative biomarkers.

Daniels S, Horman T, Lapointe T, Melanson B, Storace A, Kennedy SH, Frey BN, Rizvi SJ, Hassel S, Mueller DJ, Parikh SV, Lam RW, Blier P, Farzan F, Giacobbe P, Milev R, Placenza F, Soares CN, Turecki G, Uher R, Leri F.

J Affect Disord. 2019 Nov 23;263:353-366. doi: 10.1016/j.jad.2019.11.108. [Epub ahead of print] Review.

PMID:
31969265
14.

Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial.

Moreno ML, Goerigk SA, Bertola L, Suemoto CK, Razza LB, Moffa AH, Veronezi BP, Tort L, Nogueira BS, Gattaz WF, Fraguas R, Padberg F, Lotufo PA, Benseñor IM, Brunoni AR.

J Affect Disord. 2019 Dec 5;263:344-352. doi: 10.1016/j.jad.2019.12.009. [Epub ahead of print]

PMID:
31969264
15.

Recurrent major depressive disorder's impact on end-of-life care of cancer: A nationwide study.

Fond G, Baumstarck K, Auquier P, Fernandes S, Pauly V, Bernard C, Orleans V, Llorca PM, Lançon C, Salas S, Boyer L.

J Affect Disord. 2019 Dec 5;263:326-335. doi: 10.1016/j.jad.2019.12.003. [Epub ahead of print]

PMID:
31969262
16.

[18F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression.

Krause-Sorio B, Siddarth P, Laird KT, Ercoli L, Narr K, Barrio JR, Small G, Lavretsky H.

Int Psychogeriatr. 2020 Jan 23:1-8. doi: 10.1017/S1041610219002047. [Epub ahead of print]

PMID:
31969201
17.

Survey of NMDA receptor-related biomarkers for depression.

Chen YM, Lin CH, Lane HY.

Curr Pharm Des. 2020 Jan 22. doi: 10.2174/1381612826666200122155206. [Epub ahead of print]

PMID:
31969091
18.

Fluoxetine improves behavioural deficits induced by chronic alcohol treatment by alleviating RNA editing of 5-HT2C receptors.

Li Z, Lu Y, Liang S, Li S, Chen B, Zhang M, Xia M, Guan D, Verkhratsky A, Li B.

Neurochem Int. 2020 Jan 19:104689. doi: 10.1016/j.neuint.2020.104689. [Epub ahead of print]

PMID:
31968217
19.

Smartphone and Facebook addictions share common risk and prognostic factors in a sample of undergraduate students.

Khoury JM, Neves MCLD, Roque MAV, Freitas AAC, da Costa MR, Garcia FD.

Trends Psychiatry Psychother. 2019 Oct-Dec;41(4):358-368. doi: 10.1590/2237-6089-2018-0069.

20.

Detecting Depression in People Living with HIV in South Africa: The Factor Structure and Convergent Validity of the South African Depression Scale (SADS).

Andersen LS, Joska JA, Magidson JF, O'Cleirigh C, Lee JS, Kagee A, Witten JA, Safren SA.

AIDS Behav. 2020 Jan 21. doi: 10.1007/s10461-020-02787-4. [Epub ahead of print]

PMID:
31965430

Supplemental Content

Loading ...
Support Center